Salix Did Its Part In Developing Napo Drug, Atty Argues

Law360, New York (August 22, 2013, 6:50 PM EDT) -- Salix Pharmaceuticals Inc. took all reasonable best efforts to help Napo Pharmaceuticals Inc. develop an anti-diarrhea drug, Salix's attorney told a New York state judge during a hearing Thursday, arguing that it didn't have to develop the drug for other uses.

The drug is called crofelemer, a botanically derived anti-diarrhea medication, and the U.S. Food and Drug Administration eventually approved it for use with certain HIV/AIDS patients in 2012 after Napo brought Salix on board to revive its stalled efforts at developing the patented medication. ...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.